FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine, namely to thyrotoxicosis simulation ensured by endogastric introduction of Thyreotom in weekly graded doses 25 mkg/kg to 200 mkg/kg within 6 weeks followed by evaluation of functional activity of thyroid gland.
EFFECT: method provides creation of such thyroid gland pathology ensuring a clinical presentation of hyperfunctioning thyroid gland in blood and peripheral organs, and simulating colloid goitre pathology in thyroid parenchyma.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIAL DIAGNOSIS OF THYROID GLAND DISEASES | 2016 |
|
RU2646800C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING THYROID HYPOTHYREOSIS | 2018 |
|
RU2708260C1 |
METHOD FOR DIAGNOSING THYROID GLAND HYPERFUNCTION | 1994 |
|
RU2106109C1 |
METHOD FOR DIAGNOSING THE CASES OF HYPERTHYROSIS | 2000 |
|
RU2187954C2 |
METHOD FOR THYROID PEROXIDASE ACTIVITY DETERMINATION IN THYROID GLAND | 2015 |
|
RU2635531C2 |
METHOD FOR PRODUCING AGENTS WITH THYROID-STIMULATING ACTIVITY | 2016 |
|
RU2619863C1 |
METHOD OF ESTIMATING EFFICIENCY OF DIFFUSE TOXIC GOITER THERAPY WITH RADIOACTIVE IODINE | 2008 |
|
RU2373848C1 |
METHOD FOR DIAGNOSING THYROID DISEASES IN CATS | 2021 |
|
RU2766668C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DIFFERENT AUTOIMMUNE THYROID LESIONS | 2006 |
|
RU2315322C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF IODINE-DEFICIENCY AND IODINE-INDUCED THYROID DYSFUNCTION IN INDIVIDUALS LIVING IN REGIONS WITH IODINE DEFICIENCY | 2019 |
|
RU2728261C2 |
Authors
Dates
2009-05-27—Published
2007-11-27—Filed